Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer

Journal of the National Cancer Institute

Volumn 89, Issue 10, 1997, Pages 724-730

  Kinoshita, Hidefumi ^a   Ogawa, Osamu ^a   Kakehi, Yoshiyuki ^a   Mishina, Mutsuki ^a   Mitsumori, Kenji ^a   Itoh, Noriyuki ^a   Yamada, Hitoshi ^a   Terachi, Toshiro ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; TELOMERE;

EID: 0030942640     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.10.724     Document Type: Article

References (32)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11: 1921-9.
3. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
4. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59: 521-9.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-5.
6. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-20.
7. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
8. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
9. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 1996;93:6476-81.
10. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46: 5-27.
11. Habuchi T, Kinoshita H, Yamada H, Kakehi Y, Ogawa O, Wu WJ, et al. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Natl Cancer Inst 1994;86:1331-5.
12. Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, et al. Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 1993;53:579-84.
13. Habuchi T, Takahashi R, Yamada H, Ogawa O, Kakehi Y, Ogura K, et al. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 1993;53:3795-9.
14. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993;342:1087-8.
15. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
16. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986;135:920-2.
17. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996;2:929-32.
18. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International classification of tumours, No. 10. Geneva: World Health Organization, 1973.
19. Hermanek P, Sobin LH. TNM classification of malignant tumours. 2nd rev. 4th ed. Springer-Verlag, International Union Against Cancer (UICC), 1992.
20. Bubenik J, Perlmann P, Helmstein K, Moberger G. Cellular and humoral immune responses to human bladder carcinomas. Int J Cancer 1970;5:310-9.
21. O'Toole C, Price ZH, Ohnuki Y, Unsgaard B. Ultrastructure, karyology and immunology of a cell line originated from a human transitionalcell carcinoma. Br J Cancer 1978;38:64-76.
22. Rasheed S, Gardner MB, Rongey RW, Nelson-Rees WA, Arnstein P. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst 1977;58:881-90.
23. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
24. Beck S, O'Keeffe T, Coull JM, Koster H. Chemiluminescent detection of DNA: application for DNA sequencing and hybridization. Nucleic Acids Res 1989;17:5115-23.
25. McNemar Q. Note on the sampling error of the differences between correlated proportions or percentages. Psychometrika 1947;12:453-7.
26. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994;91: 2900-4.
27. Koss LG. Diagnostic cytology and its histopathologic bases. 4th ed. Philadelphia: Lippincott, 1992:951-63, 983-92.
28. Murphy WM. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 1990;21:886-96.
29. Esposti PL, Zajicek J. Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings. A critical re-view of 326 tumors. Acta Cytol 1972;16:529-37.
30. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-65.
31. Koss LG, Deitch D, Ramanthan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-6.
32. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23:3794-5.